|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-1-26
|
|
pubmed:abstractText |
To prospectively study the impact of (18)F fluorodeoxyglucose (FDG) positron emission tomography (PET) on clinical management of patients with non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
111-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11134203-Adult,
pubmed-meshheading:11134203-Aged,
pubmed-meshheading:11134203-Aged, 80 and over,
pubmed-meshheading:11134203-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11134203-Female,
pubmed-meshheading:11134203-Fluorodeoxyglucose F18,
pubmed-meshheading:11134203-Humans,
pubmed-meshheading:11134203-Lung Neoplasms,
pubmed-meshheading:11134203-Male,
pubmed-meshheading:11134203-Middle Aged,
pubmed-meshheading:11134203-Neoplasm Staging,
pubmed-meshheading:11134203-Patient Care Planning,
pubmed-meshheading:11134203-Prospective Studies,
pubmed-meshheading:11134203-Radiopharmaceuticals,
pubmed-meshheading:11134203-Tomography, Emission-Computed,
pubmed-meshheading:11134203-Treatment Outcome,
pubmed-meshheading:11134203-Victoria
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Alfred Hospital, Prahran, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
